Relationship between apolipoprotein C-III concentrations and high-density lipoprotein subclass distribution

Metabolism: Clinical and Experimental

Volumn 58, Issue 5, 2009, Pages 668-674

  Tian, Li ^a,b   Wu, Jin ^b   Fu, Mingde ^a,b   Xu, Yanhua ^c   Jia, Lianqun ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c Chengdu Hoist Biotechnology Co   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN 3; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PRE BETA HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; IMMUNODETECTION; MAJOR CLINICAL STUDY; MALE; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; TWO DIMENSIONAL GEL ELECTROPHORESIS;

APOLIPOPROTEIN A-I; APOLIPOPROTEIN C-II; APOLIPOPROTEIN C-III; ATHEROSCLEROSIS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; LINEAR MODELS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED;

EID: 64549115397     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.01.007     Document Type: Article

References (38)

1. Schonfeld G., and Pfleger B. The structure of human high-density lipoprotein and the levels of apolipoprotein A-I in plasma as determined by radioimmunoassay. J Clin Invest 54 (1974) 236-246
2. Fielding C.J., Shore V.G., and Fielding P.E. A protein cofactor of lecithin cholesterol acyltransferase. Biochem Biophysical Res Commun 46 (1972) 1493-1498
3. Soutar A.K., Garner C.W., Baker H.N., et al. Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin: cholesterol acyltransferase. Biochemistry 14 (1975) 3057-3064
4. Morrisett J.D., Jackson R.L., and Gotto Jr. A.M. Lipid-protein interactions in the plasma lipoproteins. Biochim Biophys Acta 472 (1977) 93-133
5. Brewer Jr. H.B. Hypertriglyceridemia: changes in the plasma lipoproteins associated with an increased risk of cardiovascular disease. Am J Cardiol 83 (1999) 3F-12F
6. Jong M.C., and Havekes L.M. Insights into apolipoprotein C metabolism from transgenic and gene-targeted mice. Int J Tissue React 22 (2000) 59-66
7. Shachter N.S. Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism. Curr Opin Lipidol 12 (2001) 297-304
8. Sacks F.M., Alaupovic P., Moye L.A., et al. VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial. Circulation 102 (2000) 1886-1892
9. Bard J.M., Charles M.A., Juhan V.I., et al., On behalf of the BIGPRO Study Group. Accumulation of triglyceride-rich lipoprotein in subjects with abdominal obesity: the biguanides and the prevention of the risk of obesity (BIGPRO) 1 study. Arterioscler Thromb Vasc Biol 21 (2001) 407-414
10. Chan D.C., Watts G.F., Redgrave T.G., et al. Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration. Metabolism 51 (2002) 1041-1046
11. Blankehorn D.H., Alaupovic P., Wickham E., et al. Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors. Circulation 81 (1990) 470-476
12. Hodis H.N., Mack W.J., Azen S.P., et al. Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin. Circulation 90 (1994) 42-49
13. Warnick G.R., Nguyen T., and Albers A.A. Comparison of improved precipitation methods for quantification of high-density lipoprotein cholesterol. Clin Chem 31 (1985) 217-222
14. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
15. Labeur C., Shepherd J., and Rosseneu M. Immunological assays of apolipoproteins in plasma: methods and instrumentation. Clin Chem 36 (1990) 591-597
16. Liu B.W. Immunoassay of human plasma apolipoproteins and clinical applications. In: Wang K.Q. (Ed). Lipoproteins and atherosclerosis (1995), People's Health Press, Beijing 359-368
17. Fielding C.J., and Fielding P.E. Molecular physiology of reverse cholesterol transport. J Lipid Res 36 (1995) 211-228
18. Schaefer E.J., Eisenberg S., and Levy R.I. Lipoprotein apoprotein metabolism. J Lipid Res 19 (1978) 667-687
19. Jackson R.L., Morrisett J.D., and Gotto Jr. A.M. Lipoprotein structure and metabolism. Physiol Rev 56 (1976) 259-316
20. Gou L.T., Fu M.D., Xu Y.H., et al. Alterations of HDL subclasses in endogenous hypertriglyceridemia. Am Heart J 150 (2005) 1039-1045
21. Yang Y.Y., Yan B.Y., Fu M.D., et al. Relationship between plasma lipid concentrations and HDL subclasses. Clin Chim Acta 354 (2005) 49-58
22. Jia L.Q., Long S.Y., Fu M.D., et al. Relationship between total cholesterol/high-density lipoprotein cholesterol ratio, triglyceride/high-density lipoprotein cholesterol ratio, and high-density lipoprotein subclasses. Metabolism 55 (2006) 1141-1148
23. Jia L.Q., Wu X.W., Fu M.D., et al. Relationship between apolipoproteins and the alteration of HDL subclasses in hyperlipidemic subjects. Clin Chim Acta 383 (2007) 65-72
24. Tian L., Jia L.Q., Fu M.D., et al. Alterations of high density lipoprotein subclasses in obese subjects. Lipids 41 (2006) 789-796
25. Brown W.V., and Baginski M.L. Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein. Biochem Biophys Res Commun 46 (1972) 375-382
26. Havel R.J., Fielding C.J., Olivecrona T., et al. Cofactor activity of protein components of human very low density lipoproteins in the hydrolysis of triglycerides by lipoprotein lipase from different sources. Biochemistry 12 (1973) 1828-1833
27. Sparks D.L., and Pritchard P.H. Transfer of cholesteryl ester into high density lipoprotein by cholesteryl ester transfer protein: effect of HDL lipid and apoprotein content. J Lipid Res 30 (1989) 1491-1498
28. Executive summary of the third report of NCEP, Expert Panel on Detection, and Evaluation and Treatment of High Blood Cholesterol in Adults. Adult Treatment Panel III. JAMA 285 (2001) 486-497
29. Tornvall P., Olivecrona G., Karpe F., et al. Lipoprotein lipase mass and activity in plasma and their increase after heparin are separate parameters with different relations to plasma lipoproteins. Arterioscler Thromb Vasc Biol 15 (1995) 1086-1093
30. Watanabe H., Miyashita Y., Murano T., et al. Preheparin serum lipoprotein lipase mass concentration: the effects of age, gender, and types of hyperlipidemias. Atherosclerosis 145 (1999) 45-50
31. Lee M., Kim J.Q., Kim J., et al. Studies on the plasma lipid profiles, and LCAT and CETP activities according to hyperlipoproteinemia phenotypes (HLP). Atherosclerosis 159 (2001) 381-389
32. Havel R.J., Kane J.P., and Kashyap M.L. Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipidemia in man. J Clin Invest 52 (1973) 32-38
33. Jong M.C., Hofker M.H., and Havekes L.M. Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. Arterioscler Thromb Vasc Biol 19 (1999) 472-484
34. Edward M., Rubin Y., Ishida S.M., et al. Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses. Biochemistry 88 (1991) 434-438
35. Kunitake S.T., Ka L., Sala K.J., et al. Apolipoprotein A-I-containing lipoproteins with pre-beta electrophoretic mobility. J Lipid Res 26 (1985) 549-555
36. Asztalos B.F., Sloop C.H., and Wong L. Two-dimensional electrophoresis of plasma lipoproteins: recognition of new apoA-I-containing subpopulations. Biochim Biophys Acta 1169 (1993) 291-300
37. Castro G.R., and Fielding C.J. Early incorporation of cell derived cholesterol into preβ-migrating high-density lipoprotein. Biochemistry 27 (1988) 25-29
38. Tian L., Fu M.D., Jia L.Q., et al. Relationship between apolipoprotein concentrations and HDL subclasses distribution. Lipids 42 (2007) 419-426